Business Daily from THE HINDU group of publications
Wednesday, Aug 02, 2006


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals
Divi's Labs Q1 net doubles

Our Bureau

Hyderabad , Aug 1

Divi's Laboratories Ltd (DLL) has reported a growth of 142 per cent in income and 110 per cent net profit for the first quarter of current fiscal ended June 30.

While turnover has improved to Rs 165 crore from Rs 68 crore in the correspondent quarter of previous fiscal, net profit rose to Rs 27 crore (Rs 13 crore).

The company has attributed the growth to significant improvement in sales to big pharma companies for the custom synthesis and also increase in business of its top-five generic products.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Bhagyanagar Metals net up at Rs 7.59 cr


HFCL net profit at Rs 18.2 cr
Goa Carbon Q4 net loss at Rs 1.17 cr
Suprajit Engg net up at Rs 3.97 cr
NCC Q1 net doubles
Punj Lloyd Q1 net at Rs 18 cr
Divi's Labs Q1 net doubles
Bal Pharma PAT rises 16.32 pc
Suven Life Q1 net up 51%
Dishman PAT up 97% at 18.5 cr
Blow Plast Q1 net dips 20 pc
Areva T&D posts Rs 27-cr net
Pennar Industries Q1 net up at Rs 6.1 cr
Bajaj Hindustan Sugar back in black
Empee Sugars triples net to Rs 1.1 cr
Suryajyoti Spinning Q1 net up 43%
Krishna Lifestyle Q1 net at Rs 1.15 cr
Nahar Industrial net rises 35 pc
Indo Asian Fusegear net up marginally
Ma Foi H1 net income up at Rs 43.5 cr
Ansal Housing net up at Rs 7.25 cr
MphasiS Q1 net drops 55 pc to Rs 15 cr
JK Paper Q4 net down 39 pc
Q1 net slips to Rs 30.3 cr
Jagran Prakashan Q1 net profit up


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line